Compare AMPH & SXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMPH | SXC |
|---|---|---|
| Founded | 1996 | 1960 |
| Country | United States | United States |
| Employees | N/A | 848 |
| Industry | Biotechnology: Pharmaceutical Preparations | Steel/Iron Ore |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 885.4M | 733.1M |
| IPO Year | 2005 | 2011 |
| Metric | AMPH | SXC |
|---|---|---|
| Price | $19.03 | $8.67 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 8 | 1 |
| Target Price | ★ $28.38 | $9.00 |
| AVG Volume (30 Days) | 542.4K | ★ 1.3M |
| Earning Date | 05-07-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 7.17% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.14 | N/A |
| Revenue | $719,887,000.00 | ★ $1,600,300,000.00 |
| Revenue This Year | $6.90 | N/A |
| Revenue Next Year | $4.64 | N/A |
| P/E Ratio | $134.11 | ★ N/A |
| Revenue Growth | N/A | ★ 10.30 |
| 52 Week Low | $16.65 | $5.52 |
| 52 Week High | $31.26 | $9.74 |
| Indicator | AMPH | SXC |
|---|---|---|
| Relative Strength Index (RSI) | 47.69 | 57.57 |
| Support Level | $18.57 | $7.69 |
| Resistance Level | $19.81 | $8.72 |
| Average True Range (ATR) | 0.86 | 0.27 |
| MACD | -0.13 | 0.04 |
| Stochastic Oscillator | 23.68 | 90.57 |
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.
SunCoke Energy Inc operates as an independent producer of coke in the Americas. Its coke is mainly used as a principal raw material in the blast furnace steelmaking process as well as in the foundry production of casted iron. The company operates through two segments: Domestic Coke and Industrial Services. It offers metallurgical and thermal coal. The company also provides handling and/or mixing services to steel, coke, electric utility, coal-producing, and other manufacturing-based customers. The majority of revenue is derived from the Domestic Coke segment.